Markets:

Overview

News

Currencies

International

Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

18.32 +0.04 (+0.25%)

Streaming Delayed Price Updated: 12:15 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Why Novavax Stock Surged Today ↗

September 07, 2021

The biotech's coronavirus-related revenue could be about to soar.

Via The Motley Fool

NVAX Stock: The Big Reason Why Novavax Shares Are Gaining Today ↗

September 07, 2021

A Japanese pharma giant has partnered with Novavax to supply millions of vaccines. NVAX stock is reacting accordingly.

Via InvestorPlace

Novavax Shares Surge On Vaccine Supply Deal With Japan ↗

September 07, 2021

Novavax, Inc. shares were trading higher Tuesday following the signing of a coronavirus vaccine supply deal.

Via Talk Markets

Novavax Shares Surge On Vaccine Supply Deal With Japan ↗

September 07, 2021

Novavax, Inc. (NASDAQ: NVAX) shares were trading higher Tuesday following the signing of a coronavirus vaccine supply deal. What Happened: Japanese pharma giant Takeda...

Via Benzinga

Mu - The Newest Worry ↗

September 03, 2021

Today London and New York fell on the huge drop in new employment levels in August.

Via Talk Markets

Analyzing Takeda Pharmaceutical's Unusual Options Activity ↗

August 03, 2021

Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ...

Via Benzinga

Understanding Takeda Pharmaceutical's Unusual Options Activity ↗

July 30, 2021

Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ...

Via Benzinga

Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study ↗

September 02, 2021

Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The trial did...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial

September 01, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Moderna Reviews Contamination In Vaccine Lot Distributed In Japan ↗

September 01, 2021

Moderna, Inc. (NASDAQ: MRNA) found itself in a controversy after Japan suspended the use of about 2.6 million doses of the company's COVID-19 vaccine following reports of...

Via Benzinga

UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma ↗

August 30, 2021

New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ)...

Via Benzinga

Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know ↗

August 30, 2021

After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19...

Via Benzinga

Topics Death

Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters ↗

August 27, 2021

Metallic particle is believed to be a contaminant found in a batch of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines delivered to Japan, Japanese public broadcaster...

Via Benzinga

Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer ↗

August 26, 2021

Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received...

Via Benzinga

Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns ↗

August 26, 2021

More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia...

Via Benzinga

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

August 18, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

Takeda To Lead Finch-Partnered Microbiome IBD Drug ↗

August 10, 2021

Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN...

Via Benzinga

Why BioCryst Pharmaceuticals Rose 8% on Thursday ↗

August 05, 2021

The company's first commercial drug launch keeps exceeding expectations.

Via The Motley Fool

Topics Earnings

Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks

August 05, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

August 01, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress

July 30, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

July 29, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag ↗

July 28, 2021

The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...

Via Benzinga

U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)

July 28, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

XBIO Stock: Xenetic Soars on Private Placement Announcement ↗

July 26, 2021

XBIO stock is continuing a heck of a week. Just days after it was boosted by Takeda's expansion news, it's looking at a big private sale.

Via InvestorPlace

Containment Plan ↗

July 23, 2021

Today the US decided to cut China risks.

Via Talk Markets

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.